John D. Lueck

Also affiliated with University of Rochester

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs”.

Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs

Molecular Therapy — Nucleic Acids(2022)10.1016/j.omtn.2022.04.033

N/A

0.655DataRank · unranked

78 citations

Joseph J. Porter, Matthew T. Sipple, Katherine M. Edwards, John D. Lueck, Wooree Ko

Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2022.12.016

N/A

0DataRank · unranked

24 citations

Uta Griesenbach, Batsheva Kerem, John D. Lueck, Noemie Stanleigh, Yifat S. Oren +1 more

Photomodulation of the ASIC1a acidic pocket destabilizes the open state

Protein Science(2023)10.1002/pro.4800

N/A

0DataRank · unranked

7 citations

Tyler W. McCullock, Tyler Couch, John D. Lueck, David M. MacLean, Matthew L. Rook

Combinatorial chloride and calcium channelopathy in myotonic dystrophy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.29.542752

N/A

0DataRank · unranked

1 citations

Matthew T. Sipple, Katherine M. Edwards, Charles A. Thornton, John D. Lueck, Lily A. Cisco

277 Nonsense suppressor tRNA picovectors represent a new therapeutic cargo for the treatment of premature termination codon–associated cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01205-5

N/A

0DataRank · unranked

0 citations

E. L. Sorensen, Wooree Ko, John D. Lueck, J. Porter

Optimization of ACE-tRNAs function in translation for suppression of nonsense mutations

Nucleic Acids Research(2024)10.1093/nar/gkae1112

N/A

0DataRank · unranked

22 citations

Wooree Ko, Emily G. Sorensen, John D. Lueck, Joseph J. Porter

Engineered tRNAs efficiently suppress CDKL5 premature termination codons

Scientific Reports(2024)10.1038/s41598-024-82766-0

N/A

0DataRank · unranked

13 citations

Aurora Mustaccia, Pierre Aboa, Giorgia Faustini, Alessio Branchini, Mirko Pinotti +5 more

Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model

Journal of Clinical Investigation(2024)10.1172/jci173576

N/A

0DataRank · unranked

26 citations

Matthew T. Sipple, Katherine M. Edwards, Charles A. Thornton, John D. Lueck, Lily A. Cisco

A cystic fibrosis gene editing approach that is on target

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102197

N/A

0DataRank · unranked

1 citations

John D. Lueck, Joseph J. Porter

Optimization of Anticodon Edited Transfer RNAs (ACE-tRNAs) Function in Translation for Suppression of Nonsense Mutations

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.11.575297

N/A

0DataRank · unranked

2 citations

Wooree Ko, Emily G. Sorensen, John D. Lueck, Joseph J. Porter

Gz Enhanced Signal Transduction assaY (G Z ESTY) for GPCR deorphanization

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.26.605282

N/A

0DataRank · unranked

0 citations

Joseph J. Porter, John D. Lueck, Cesare Orlandi, Luca Franchini

Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.13.623453

N/A

0DataRank · unranked

0 citations

A.A. Bhattacharya, Hong Li, John D. Lueck, Yale E. Goldman, Barry S. Cooperman +1 more

ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis

Nucleic Acids Research(2025)10.1093/nar/gkaf675

N/A

0DataRank · unranked

13 citations

Joseph J. Porter, Sacha Spelier, Emily G. Sorensen, Priyanka Bhatt, J. Gabell +7 more

GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization

Nature Communications(2025)10.1038/s41467-025-59850-8

N/A

0DataRank · unranked

4 citations

Joseph J. Porter, John D. Lueck, Cesare Orlandi, Luca Franchini

Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases

Nucleic Acids Research(2025)10.1093/nar/gkaf216

N/A

0DataRank · unranked

2 citations

A.A. Bhattacharya, Hong Li, Xiaonan Cui, John D. Lueck, Yale E. Goldman +2 more

Anticodon Edited Transfer RNAs (ACE-tRNAs) Encoded as Therapeutic Nonviral Minimal DNA Vectors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.06.674645

N/A

0DataRank · unranked

0 citations

Wooree Ko, Emily G. Sorensen, Zachary Cheung, Tyler Couch, J. Gabell +7 more

Elimination of myotonia improves myopathy in a muscleblind knockout model of myotonic dystrophy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.19.677400

N/A

0DataRank · unranked

0 citations

Shuji Hamazaki, Vanessa Todorow, Lily A. Cisco, Katherine M Lupia, Christina S. Heil +4 more

Efficient Suppression of Endogenous CFTR Nonsense Mutations Using Anticodon Engineered Transfer RNAs

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.09.463783

N/A

0DataRank · unranked

0 citations

Joseph J. Porter, Matthew T. Sipple, Katherine M. Edwards, John D. Lueck, Wooree Ko

Subnuclear organization and mislocalization of plasmids reduce transgene expression

Molecular Therapy — Nucleic Acids(2025)10.1016/j.omtn.2025.102730

N/A

0DataRank · unranked

0 citations

Uday Baliga, Joseph J. Porter, John D. Lueck, David A. Dean, Na‐Yeon Gu